紫杉醇同步放化疗治疗晚期子宫内膜癌的疗效分析
资料和方法,结果,讨论
【摘要】目的:分析针对晚期子宫内膜癌患者展开紫杉醇同步放化疗所起到的临床疗效。方法:本次实验对象为2020年3月—2022年3月在我院接受治疗的80例晚期子宫内膜癌患者,并将其按照随机数表法分为对照组和观察组,每组有40例患者。对照组患者采用常规治疗模式,仅采用放疗和顺铂化疗作为治疗方式,而观察组患者则采用紫杉醇同步放化疗的综合疗法。对比两组患者的临床疗效、不良反应发生率以及复发率。结果:观察组患者的临床疗效明显高于对照组(P<0.05),不良反应发生率明显低于对照组(P<0.05),复发率明显低于对照组(P<0.05)。结论:将紫杉醇同步放化疗的综合疗法应用于晚期子宫内膜癌患者的治疗过程中,能够帮助患者有效延缓病情发展,减少治疗期间普遍存在的不良反应,降低复发风险,为患者战胜癌症提供新的希望。【关键词】紫杉醇;放疗;化疗;晚期子宫内膜癌
Analysis of the therapeutic effect of paclitaxel synchronous radiotherapy and chemotherapy in the treatment of advanced endometrial cancer
LI Qingchuan, ZHANG Yuzi
Department of Oncology, Fourth People’s Hospital of Zibo City, Zibo, Shandong 255400, China
【Abstract】Objective:To analyze the clinical efficacy of paclitaxel synchronous radiotherapy and chemotherapy in patients with advanced endometrial cancer.Methods:The subjects of this experiment were 80 patients with advanced endometrial cancer who received treatment in our hospital from March 2020 to March 2022.They were randomly divided into the control group and the observation group using a random number table method ......
您现在查看是摘要页,全文长 8920 字符。